EXOZ - eXoZymes, Inc. News

EXOZ

eXoZymes, Inc.

8.25

1 x 8.20

4 x 8.63

bid

ask

0.25

2.94%

10:16 AM

timesize

Ytd	-24.31%
1y	-19.12%

8.04

day range

8.49

6.33

52 week range

18.40

Open	8.18	Prev Close	8.50	Low	8.04	High	8.49	Mkt Cap	79.73M
Vol	9.03K	Avg Vol	7.16K	EPS	-1.15	P/E	N/A	Forward P/E	N/A
Beta	N/A	Short Ratio	N/A	Inst. Own	N/A	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	05-12	50-d Avg	9.16	200-d Avg	11.03	1yr Est	0.00

EXOZ News

benzinga.com

eXoZymes Wins $2M NIH Grant To Advance Cannabinoid Analogs For Drug Discovery

Award allows eXoZymes to expand its portfolio of proprietary new-to-nature molecules and potential f

accessnewswire.com

eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery

Award allows eXoZymes to expand its portfolio of proprietary new-to-nature molecules and potential f

accessnewswire.com

eXoZymes Inc. Announces Closing of $6 Million Public Offering

LOS ANGELES, CA / ACCESS Newswire / June 17, 2026 / eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes" or "Comp

benzinga.com

eXoZymes Prices ~$5.33M Offering Of Units At $18/Unit

eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes" or "Company") - a pioneer of AI-enhanced enz

accessnewswire.com

eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants

LOS ANGELES, CA / ACCESS Newswire / June 8, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes" or

accessnewswire.com

eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program

LOS ANGELES, CA / ACCESS Newswire / May 7, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") -

accessnewswire.com

eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanuf

LOS ANGELES, CA / ACCESS Newswire / April 10, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes")

accessnewswire.com

eXoZymes Provides Fourth Quarter and Full Year 2025 Update

Management to Host Conference Call Today at 5:30 PM Eastern LOS ANGELES, CA / ACCESS Newswire / Marc

benzinga.com

Earnings Scheduled For March 31, 2026

accessnewswire.com

eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026

LOS ANGELES, CA / ACCESS Newswire / March 25, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes")

accessnewswire.com

Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability

LOS ANGELES, CA / ACCESS Newswire / March 18, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes")

accessnewswire.com

eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium

LOS ANGELES, CA / ACCESS Newswire / March 12, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes")

defenseworld.net

Head-To-Head Analysis: eXoZymes (NASDAQ:EXOZ) & Curis (NASDAQ:CRIS)

eXoZymes (NASDAQ: EXOZ - Get Free Report) and Curis (NASDAQ: CRIS - Get Free Report) are both small-

accessnewswire.com

With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term

LOS ANGELES, CALIFORNIA / ACCESS Newswire / February 10, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) (

defenseworld.net

Critical Review: eXoZymes (NASDAQ:EXOZ) vs. Disc Medicine (NASDAQ:IRON)

eXoZymes (NASDAQ: EXOZ - Get Free Report) and Disc Medicine (NASDAQ: IRON - Get Free Report) are bot

benzinga.com

Reported Earlier, eXoZymes Achieves High Conversion Yield And 99.6% Purity In Initial NCT Pilot Run

N-trans-caffeoyltyramine (NCT) is an interesting naturally occurring compound that has attracted sci

accessnewswire.com

eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run

N-trans-caffeoyltyramine (NCT) is an interesting naturally occurring compound that has attracted sci

defenseworld.net

eXoZymes (NASDAQ:EXOZ) Stock Price Down 1.7% – Here’s Why

eXoZymes Inc. (NASDAQ: EXOZ - Get Free Report) traded down 1.7% during mid-day trading on Monday. Th

accessnewswire.com

eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedsto

LOS ANGELES, CALIFORNIA / ACCESS Newswire / December 11, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) (

accessnewswire.com

eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today

Management to host Q3 2025 update at 5:00PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Ne

accessnewswire.com

eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of

LOS ANGELES, CA / ACCESS Newswire / November 13, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZyme

benzinga.com

Earnings Scheduled For November 13, 2025

accessnewswire.com

eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST

LOS ANGELES, CALIFORNIA / ACCESS Newswire / November 10, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) (

benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

accessnewswire.com

CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference

LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 30, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("

accessnewswire.com

CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference

LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 29, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("

benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga.com

12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com

Earnings Scheduled For April 2, 2025

benzinga.com

12 Health Care Stocks Moving In Thursday's Intraday Session